Guided Therapeutics, Inc. (GTHP)
OTCMKTS · Delayed Price · Currency is USD
0.2280
0.00 (0.00%)
At close: Jun 3, 2026
Guided Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.77 | 0.77 | 0.01 | 0.1 | 0.01 | 0.08 | |
Revenue Growth (YoY) | 76600.00% | 10857.14% | -92.86% | 653.85% | -83.95% | -20.59% |
Cost of Revenue | 0.2 | 0.2 | 0.01 | 0.06 | 0.08 | 0.06 |
Gross Profit | 0.57 | 0.57 | 0 | 0.04 | -0.07 | 0.02 |
Selling, General & Admin | 2.61 | 2.47 | 1.58 | 2.53 | 3.19 | 2.31 |
Research & Development | 0.44 | 0.47 | 0.53 | 0.23 | 0.08 | 0.07 |
Operating Expenses | 2.83 | 2.94 | 2.11 | 2.75 | 3.27 | 2.38 |
Operating Income | -2.26 | -2.37 | -2.11 | -2.72 | -3.33 | -2.36 |
Interest Expense | -0.62 | -0.62 | -0.38 | -0.28 | -0.58 | -1.15 |
Interest & Investment Income | - | - | 0 | 0.01 | - | - |
Other Non Operating Income (Expenses) | 0.03 | 0.23 | - | 0.04 | 0.04 | 0.86 |
EBT Excluding Unusual Items | -2.85 | -2.76 | -2.49 | -2.95 | -3.87 | -2.65 |
Other Unusual Items | -0.42 | -0.44 | 0.07 | -0.54 | -0.47 | 0.58 |
Pretax Income | -3.27 | -3.2 | -2.42 | -3.49 | -4.34 | -2.07 |
Net Income | -3.27 | -3.2 | -2.42 | -3.49 | -4.34 | -2.07 |
Preferred Dividends & Other Adjustments | 0.63 | 0.15 | 0.17 | 0.27 | 0.63 | 0.36 |
Net Income to Common | -3.9 | -3.35 | -2.59 | -3.76 | -4.97 | -2.43 |
Shares Outstanding (Basic) | 84 | 78 | 57 | 51 | 33 | 13 |
Shares Outstanding (Diluted) | 84 | 78 | 57 | 51 | 33 | 13 |
Shares Change (YoY) | 37.59% | 36.75% | 12.14% | 57.30% | 142.99% | 24.24% |
EPS (Basic) | -0.05 | -0.04 | -0.05 | -0.07 | -0.15 | -0.18 |
EPS (Diluted) | -0.05 | -0.04 | -0.05 | -0.07 | -0.15 | -0.18 |
Free Cash Flow | -1.36 | -1.07 | -1.12 | -1.75 | -1.51 | -1.61 |
Free Cash Flow Per Share | -0.02 | -0.01 | -0.02 | -0.03 | -0.05 | -0.12 |
Gross Margin | 74.45% | 74.45% | 28.57% | 36.73% | - | 24.69% |
Operating Margin | -294.65% | -309.26% | -30114.29% | -2773.29% | -25638.46% | -2916.05% |
Profit Margin | -507.95% | -436.25% | -37014.29% | -3835.71% | -38246.15% | -3001.24% |
Free Cash Flow Margin | -176.79% | -139.50% | -15985.71% | -1781.63% | -11615.39% | -1982.72% |
EBITDA | -2.25 | -2.36 | -2.1 | -2.71 | -3.33 | -2.36 |
D&A For EBITDA | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 |
EBIT | -2.26 | -2.37 | -2.11 | -2.72 | -3.33 | -2.36 |